Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 140Leukemia, Myeloid, Acute 120Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Myeloproliferative Disorders 57Lymphoma 56Lymphoma, Non-Hodgkin 55Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic-Phase 52Multiple Myeloma 51Leukemia, Myelomonocytic, Chronic 50Hodgkin Disease 49Congenital Abnormalities 47Leukemia, Myeloid, Accelerated Phase 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Primary Myelofibrosis 40Blast Crisis 39Anemia, Refractory, with Excess of Blasts 38Lymphoma, Follicular 37Lymphoma, Large B-Cell, Diffuse 36Lymphoma, Mantle-Cell 35Burkitt Lymphoma 35Myelodysplastic-Myeloproliferative Diseases 34Lymphoma, B-Cell, Marginal Zone 33Neoplasms, Plasma Cell 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 31Graft vs Host Disease 24Dendritic Cell Sarcoma, Interdigitating 23Polycythemia Vera 21

Interventions

Radiotherapy 1Methylprednisolone 1Melphalan 1Imatinib Mesylate 1Fentanyl 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Busulfan × Myeloid × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡